The TPP Is Dead. Long Live Free Trade.
Executive Summary
With the Trans-Pacific Partnership multinational trade deal seemingly dead in the water, attention is now turning to potential alternative trade agreements in the Asia-Pacific region. But how might these play out for the global pharma industry?
You may also be interested in...
Why Now Is The Right Time For Mutual Recognition
20 years later, signs that this time the US EU mutual recognition agreement won’t fizzle.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Teva’s immunology biosimilar launches; Intra-Cellular’s promising depression data; Phase III sleep apnea win for Lilly’s tirzepatide; an interview with Viking’s CEO; and China looks to define innovative drugs.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.